⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14126624 | 0.79 | — | — | |
| SCHEMBL11746601 | 0.79 | — | — | |
| SCHEMBL28651066 | 0.76 | — | — | |
| SCHEMBL25690276 | 0.74 | — | — | |
| SCHEMBL5573 | 0.72 | — | — | |
| SCHEMBL15075 | 0.72 | — | — | |
| SCHEMBL21791614 | 0.72 | — | — | |
| SCHEMBL18789236 | 0.72 | CHRM2 (0.40) | — | |
| SCHEMBL13872862 | 0.70 | — | — | |
| SCHEMBL23304293 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3844144-B1 | NEW FUNCTIONALISED TETRAZENE COMPOUNDS | ARIANEGROUP SAS (FR) | 2023-12-13 | — | — | EP | claimed |
| EP-3844144-B1 | NEW FUNCTIONALISED TETRAZENE COMPOUNDS | ARIANEGROUP SAS (FR) | 2023-12-13 | — | — | EP | disclosed |
| EP-3844144-B1 | NEW FUNCTIONALISED TETRAZENE COMPOUNDS | ARIANEGROUP SAS (FR) | 2023-12-13 | — | — | EP | disclosed |
| US-20230174488-A1 | SARS-COV-2 INHIBITORS HAVING COVALENT MODIFICATIONS FOR TREATING CORONAVIRUS INFECTIONS | INSILICO MEDICINE IP LIMITED (HK) | 2023-06-08 | — | — | US | disclosed |
| WO-2023072301-A1 | PYRAZOLO[3,4-D]PYRIMIDIN-3-ONE COMPOUND AND MEDICAL USE THEREOF | 正大天晴药业集团股份有限公司 | 2023-05-04 | — | — | WO | disclosed |
| EP-3747883-A1 | MONOCYCLIC B-LACTAM COMPOUND FOR TREATING BACTERIAL INFECTION | Medshine Discovery Inc. (CN) | 2020-12-09 | — | — | EP | disclosed |
| WO-2020043997-A1 | NEW FUNCTIONALISED TETRAZENE COMPOUNDS | ARIANEGROUP SAS (FR) | 2020-03-05 | — | — | WO | disclosed |
| EP-2678035-B1 | PHENALENE-1-ONE DERIVATIVES, METHOD FOR PRODUCING SAME AND USE THEREOF | TRIOPTOTEC GMBH (DE) | 2019-04-10 | — | — | EP | disclosed |
| CN-108283644-A | To the instantaneous protection of normal cell during chemotherapy | G1治疗公司 | 2018-07-17 | — | — | CN | disclosed |
| US-20170145012-A1 | PURINONES AS UBIQUITIN-SPECIFIC PROTEASE 1 INHIBITORS | FORMA THERAPEUTICS, INC. | 2017-05-25 | — | — | US | disclosed |
| US-5741912-A | DIAGNOSIS, THERAPY | BRACCO INTERNATIONAL B.V. | 1998-04-21 | — | — | US | disclosed |
| US-5665329-A | Heteroatom-bearing ligands and metal complexes thereof | BRACCO INTERNATIONAL B.V. | 1997-09-09 | — | — | US | disclosed |
| US-5656254-A | Polyaza heteroatom-bearing ligands and metal complexes thereof for imaging or radiotherapy | BRACCO INTERNATIONAL B.V. | 1997-08-12 | — | — | US | disclosed |
| US-5627286-A | Heteroatom-bearing ligands and metal complexes thereof | BRACCO INTERNATIONAL B.V. | 1997-05-06 | — | — | US | disclosed |
| US-5608110-A | Heteroatom-bearing ligands and metal complexes thereof | BRACCO INTERNATIONAL B.V. | 1997-03-04 | — | — | US | disclosed |
| CN-1099388-A | Heteroatom-bearing ligands and metal complexes thereof | BRISTOL MYERS SQIBB COMPANY (US) | 1995-03-01 | — | — | CN | disclosed |
| EP-0629617-A1 | Heteroatom-bearing ligands and metal complexes thereof | BRACCO International B.V. (NL) | 1994-12-21 | — | — | EP | disclosed |
| US-4268486-A | REACTING WITH A HYDRAZINE COMPOUND AND SEPARATING TRIVALENT CHROMIUM COMPOUNDS | OLIN CORPORATION (US) | 1981-05-19 | — | — | US | disclosed |
| US-4002625-A | HERBICIDES, INSECTICIDES, ANTIMICROBIALS | THE DOW CHEMICAL COMPANY (US) | 1977-01-11 | — | — | US | disclosed |
| US-3962113-A | METHOD FOR ACCELERATING OXYGEN REMOVAL EMPLOYING AN AQUEOUS SOLUTION OF AN ALKYL HYDRAZINE | OLIN CORPORATION (US) | 1976-06-08 | — | — | US | disclosed |